122 related articles for article (PubMed ID: 9732103)
1. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
[TBL] [Abstract][Full Text] [Related]
2. [Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma].
Niewczas M; Paczek L; Krawczyk M; Pawlak J; Bartłomiejczyk I; Górnicka B
Pol Arch Med Wewn; 2002 Jul; 108(1):653-62. PubMed ID: 12412410
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-2-antichymotrypsin in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kiluk S; Gluszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):817-23. PubMed ID: 2467852
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic activity and serum protease inhibitors in nasal secretions from adult patients with common colds.
Hamaguchi Y; Ohi M; Ukai K; Sakakura Y; Miyoshi Y
Rhinology; 1986 Jun; 24(2):125-32. PubMed ID: 2943014
[TBL] [Abstract][Full Text] [Related]
6. Trypsin, elastase, plasmin and MMP-9 activity in the serum during the human ageing process.
Paczek L; Michalska W; Bartlomiejczyk I
Age Ageing; 2008 May; 37(3):318-23. PubMed ID: 18332058
[TBL] [Abstract][Full Text] [Related]
7. Serum alkaline-stable acid thiol proteinase--a possible marker for primary liver carcinoma.
Dufek V; Matous B; Král V
Neoplasma; 1984; 31(1):99-107. PubMed ID: 6142423
[TBL] [Abstract][Full Text] [Related]
8. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
9. Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma.
Wozniak A; Mila-Kierzenkowska C; Schachtschabel DO; Wozniak B; Rozwodowska M; Drewa T; Drewa S; Sir J; Sir I; Maciak R; Krzyzynska-Malinowska E
Exp Oncol; 2005 Sep; 27(3):233-7. PubMed ID: 16244588
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
Mero M; Tenhunen R; Pessi T; Sandholm M
Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
[TBL] [Abstract][Full Text] [Related]
11. [Acute-phase proteins in colorectal cancer].
Dumitraşcu D; Stanciu L; Radu D; Dejica D; Ban A; Ioniţă A; Petcovici M; Duca S; Cazacu M; Funaru G
Med Interna; 1992; 44(2-4):41-6. PubMed ID: 1285361
[No Abstract] [Full Text] [Related]
12. Changes in serum cathepsin B-like activity in patients with colorectal cancer.
Dufek V; Jirásek V; Král V; Matous B; Drazná E
Neoplasma; 1985; 32(1):51-4. PubMed ID: 3982561
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
14. Activity of lysosomal and nonlysosomal proteases and contents of protein and its degradation products in the blood serum of rats with fibrosarcoma induced by methylcholanthrene.
Gołaszewski Z; Pałka J; Sobolewski K; Ostrowska H; Gołaszewska J
Rocz Akad Med Bialymst; 1997; 42(1):218-24. PubMed ID: 9581483
[TBL] [Abstract][Full Text] [Related]
15. [Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer].
Dumitraşcu D; Radu D; Stanciu L; Ioniţă A; Petcovici M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):57-61. PubMed ID: 2479968
[TBL] [Abstract][Full Text] [Related]
16. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease.
Pederson ED; Stanke SR; Whitener SJ; Sebastiani PT; Lamberts BL; Turner DW
Arch Oral Biol; 1995 Dec; 40(12):1151-5. PubMed ID: 8850655
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
[TBL] [Abstract][Full Text] [Related]
18. Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
Fabris C; Del Favero G; Panucci A; Plebani M; Di Mario F; Piccoli A; Basso D; Burlina A; Naccarato R
Enzyme; 1986; 35(2):82-6. PubMed ID: 2427333
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
20. Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms.
Chawla RK; Lawson DH; Sarma PR; Nixon DW; Travis J
Cancer Res; 1987 Feb; 47(4):1179-84. PubMed ID: 3492270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]